What Researchers Did
Researchers conducted a narrative review synthesizing studies published between 2004 and 2024 to explore the mechanisms, advances, and clinical potential of stem cell therapy for osteoradionecrosis of the jaws (ORNJ).
What They Found
Osteoradionecrosis of the jaws affects 1.2% to 40% of patients receiving over 60 Gy radiotherapy for head-and-neck cancers. Preclinical studies in rodent models demonstrated that local transplantation of mesenchymal stem cells significantly increased bone volume and bone mineral density, attributed to their multidirectional differentiation, paracrine signaling, and immunomodulatory functions.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A key limitation is the current reliance on preclinical evidence, indicating a need for more human clinical trials to confirm the efficacy and safety of stem cell therapy for ORNJ.